WitrynaAll the latest Imugene Limited (ASX:IMU) share price movements, news, expert commentary and investing advice from The Motley Fool Australia. WitrynaThe analyst consensus target price for shares in Imugene is AU$0.53. That is 278.57% above the last closing price of AU$0.14 . Analysts covering Imugene currently have a …
IMUGENE LIMITED (ASX:IMU) - Right now, page-1 - HotCopper ASX Share …
WitrynaView live IMUGENE LIMITED chart to track its stock's price action. Find market predictions, IMU financials and market news. Witryna22 wrz 2024 · The ASX 200 health stocks index (XHJ) has lifted by 0.30% at the time of writing, compared to the broader ASX 200 index which fell by 0.17%. Biotech high flyer Imugene (ASX:IMU) rose by 6.5% this morning, after receiving a patent grant in Japan for its HER-Vaxx immunotherapy, currently in development to treat HER2-positive gastric … how to stain wood railing
IMUGENE LIMITED (ASX:IMU) - Right now, page-1 - HotCopper ASX Share …
Witryna9 kwi 2024 · The company has issued 300m more shares resulting in dilution to shares. We achieve a 75% TAM, of the 6.45m patients in high income countries. The exchange rate remains unchanged, and we trade at a high 20 times multiplier. This would achieve a share price of $161.91 and represent a 1000+ bagger. WitrynaCurrent share price for IMU : $0.140 0.005 (3.70%) Imugene Limited (IMU), an ASX-listed company, is an Australian immuno-oncology focused Biopharmaceutical Company developing range of new and novel immune therapies that seek to activate the immune system of cancer patients to treat and eradicate tumours. Witryna2 maj 2024 · Shares dropped 9 per cent to trade at 20 cents at 1:45 pm AEST. Shares in Imugene (IMU) have slid to their lowest price in a year following the termination of a supply agreement with MSD. The company partnered with Merck Sharp and Dohme (MSD), a tradename of Merck & Co, in March to collaborate on a clinical trial … reach me in spanish